• Pacira BioSciences Announces Investment in Spine BioPharma americanpharmaceuticalreview
    April 21, 2021
    Pacira BioSciences, Inc., the industry leader in its commitment to non-opioid pain management and regenerative health solutions, announced a $3 million investment in Spine BioPharma in the form of a convertible note.
PharmaSources Customer Service